Gordian Biotechnology
PrivateLast Round
Series A
Dec 31, 2021
Est. Valuation
$170M
Total Funding Raised
$61.96M
Company Overview
Gordian Biotechnology is a biotechnology company that has developed an in vivo gene therapy discovery platform aimed at identifying and validating therapeutic targets for complex age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gordian Biotechnology Comparables
Compare Gordian Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tahoe Therapeutics | 81% | |
| Manifold Bio | 79% | |
| Octant | 74% | |
Gordian Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 31, 2021 | ||||
| Grant | Feb 1, 2021 | ||||
| Accelerator | Mar 16, 2020 |
Gordian Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizons Ventures | Series A |
| NIH RADx | Grant |
| Founders Fund | Series A |
| GigaFund | Series A |
| Y Combinator | Accelerator |
| The Longevity Fund | Series A |
| National Institute of Environmental Health Sciences | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2026
Partnership to accelerate discovery of drug targets for obesity.
- Aug 25, 2025
Tier 5 sponsor for the 12th Aging Research & Drug Discovery Meeting.
Gordian Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Gordian Biotechnology's valuation, stock price, and market status.